Literature DB >> 2792130

Cardiac involvement in glycogen storage disease type III.

S W Moses1, K L Wanderman, A Myroz, M Frydman.   

Abstract

Twenty patients with enzymatically proven glycogen storage disease type III (GSD III) aged 3-30 years underwent cardiological evaluation. Seventeen showed subclinical evidence of cardiac involvement in form of ventricular hypertrophy on ECG. Of 16 patients in whom an ECG examination was performed, 13 had abnormal echocardiographic features. Only 2 patients had cardiomegaly on X-ray. The cardiac findings in 1 of the patients, a 25-year-old female with clinically evident cardiomyopathy are described in detail. In view of our findings, patients with established GSD III, should not only be investigated regarding their muscular involvement, but should also undergo a detailed evaluation of their cardiac status.

Entities:  

Mesh:

Year:  1989        PMID: 2792130     DOI: 10.1007/bf00443106

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  [Glycogenosis type III myocardiopathy].

Authors:  A M Rossignol; M Meyer; B Rossignol; M P Palcoux; E J Raynaud; M Bost
Journal:  Arch Fr Pediatr       Date:  1979-03

2.  Gross cardiac involvement in glycogen storage disease type 3.

Authors:  C G Miller; G A Alleyne; S E Brooks
Journal:  Br Heart J       Date:  1972-08

3.  The subgroups of type 3 glycogenosis.

Authors:  F Van Hoof; H G Hers
Journal:  Eur J Biochem       Date:  1967-10

4.  Amino acid disturbances in type III glycogenosis: differences from type I glycogenosis.

Authors:  A E Slonim; R A Coleman; S Moses; N Bashan; E Shipp; P Mushlin
Journal:  Metabolism       Date:  1983-01       Impact factor: 8.694

5.  Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy.

Authors:  L J Olson; G S Reeder; K L Noller; W D Edwards; R R Howell; V V Michels
Journal:  Am J Cardiol       Date:  1984-03-15       Impact factor: 2.778

6.  Debrancher deficiency: neuromuscular disorder in 5 adults.

Authors:  S DiMauro; G B Hartwig; A Hays; A B Eastwood; R Franco; M Olarte; M Chang; A D Roses; M Fetell; R S Schoenfeldt; L Z Stern
Journal:  Ann Neurol       Date:  1979-05       Impact factor: 10.422

7.  Neuromuscular involvement in glycogen storage disease type III.

Authors:  S W Moses; N Gadoth; N Bashan; E Ben-David; A Slonim; K L Wanderman
Journal:  Acta Paediatr Scand       Date:  1986-03
  7 in total
  16 in total

1.  Glycogen storage disease type III in Inuit children.

Authors:  Paul James A Zimakas; Celia J Rodd
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

Review 2.  Gene therapy for glycogen storage diseases.

Authors:  Priya S Kishnani; Baodong Sun; Dwight D Koeberl
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

3.  Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III.

Authors:  P Lee; M Burch; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Cardiac Pathology in Glycogen Storage Disease Type III.

Authors:  S L Austin; A D Proia; M J Spencer-Manzon; J Butany; S B Wechsler; P S Kishnani
Journal:  JIMD Rep       Date:  2012-01-31

5.  Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient.

Authors:  Christiaan P Sentner; Kadir Caliskan; Wim B Vletter; G Peter A Smit
Journal:  JIMD Rep       Date:  2011-12-13

6.  Correction of glycogen storage disease type III with rapamycin in a canine model.

Authors:  Haiqing Yi; Elizabeth D Brooks; Beth L Thurberg; John C Fyfe; Priya S Kishnani; Baodong Sun
Journal:  J Mol Med (Berl)       Date:  2014-02-08       Impact factor: 4.599

Review 7.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

8.  Cardiomyopathy of glycogen storage disease type III.

Authors:  J S Carvalho; E E Matthews; J V Leonard; J Deanfield
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

9.  Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.

Authors:  A I Dagli; R T Zori; H McCune; T Ivsic; M K Maisenbacher; D A Weinstein
Journal:  J Inherit Metab Dis       Date:  2009-03-30       Impact factor: 4.982

Review 10.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.